80 related articles for article (PubMed ID: 2978428)
1. [Sensitivity of Staphylococcus aureus strains to 2d and 3d generation cephalosporins].
Ziółkowski G; Dudzińska G; Sakiel S
Pol Tyg Lek; 1988 Dec; 43(49):1592-4. PubMed ID: 2978428
[No Abstract] [Full Text] [Related]
2. [Antibiotic prophylaxis in surgery. Biological basis for the use of 2d-generation cephalosporins].
Bergogne-Berezin E; Fleiderman S
Ann Chir; 1987 Feb; 41(1):53-7. PubMed ID: 3619351
[No Abstract] [Full Text] [Related]
3. [Comparison of the in vitro activity of several cephalosporins on Staphylococcus aureus strains isolated in hospitals of northern Chile].
Godoy J; Silva J; Pizarro E; Huerta H
Rev Med Chil; 1986 Sep; 114(9):856-63. PubMed ID: 3495023
[No Abstract] [Full Text] [Related]
4. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of cephamandole--a new antibiotic.
Goyal P; Bhatia R; Baveja UK; Agarwal DS
J Commun Dis; 1982 Jun; 14(2):130-3. PubMed ID: 6818272
[No Abstract] [Full Text] [Related]
6. Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
Wagenvoort JH; Brus-Weijer L; Michel MF
Arzneimittelforschung; 1986 Sep; 36(9):1301-2. PubMed ID: 3539124
[TBL] [Abstract][Full Text] [Related]
7. Optimal disk susceptibility testing of Staphylococcus epidermidis and aureus against penicillinase-resistant semisynthetic penicillins and cephalosporins.
Wybo I; Pierard D; Lauwers S
J Chemother; 1989 Jul; 1(4 Suppl):324-5. PubMed ID: 16312422
[No Abstract] [Full Text] [Related]
8. "Cephem-induced vancomycin resistance" observed in phenotypically methicillin-sensitive Staphylococcus aureus isolated from a patient treated with vancomycin and cephems.
Iwakawa K; Kizu J; Hosaka Y; Yamamoto K
Jpn J Infect Dis; 2000 Aug; 53(4):167-9. PubMed ID: 11056561
[No Abstract] [Full Text] [Related]
9. Correlation of antibiogram, phage typing and penicillinase production of Staphylococcus aureus isolated from clinical material.
Sunderrajan P; Kale VV
J Postgrad Med; 1984 Jan; 30(1):33-7. PubMed ID: 6232376
[No Abstract] [Full Text] [Related]
10. Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin.
Blandino G; Dubini F; Russo G; Cocuzza G
Clin Ther; 1980; 3(Spec Issue):103-11. PubMed ID: 6446383
[No Abstract] [Full Text] [Related]
11. In vitro susceptibility of clinical bacterial isolates to aminoglycosides and third-generation cephalosporins.
Charoenphol I; Leelaporn A; Pongpech P; Dhiraputra C
J Med Assoc Thai; 1983 Aug; 66(8):470-4. PubMed ID: 6644210
[No Abstract] [Full Text] [Related]
12. [Phage types of Staphylococcus aureus strains and their antibiotic resistance in carriers of medical students population].
Wiśniewska K; Piechowicz L; Dabrowska-Szponar M; Haras K
Med Dosw Mikrobiol; 2007; 59(4):287-92. PubMed ID: 18416120
[TBL] [Abstract][Full Text] [Related]
13. [Phage-typing in the surveillance of hospital infections: tests on strains of Staphylococcus aureus].
Moiraghi Ruggenini A; Vanini GC; Maury F; Grassi R; Garella D
G Batteriol Virol Immunol; 1983; 76(7-12):218-26. PubMed ID: 6241575
[TBL] [Abstract][Full Text] [Related]
14. Quality control. Treatment of the 'persistent offender'.
Stokes EJ
Proc R Soc Med; 1975 Oct; 68(10):611-3. PubMed ID: 1108032
[No Abstract] [Full Text] [Related]
15. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
[TBL] [Abstract][Full Text] [Related]
16. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
Corser CA; Day GJ; Humble MW
N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
[TBL] [Abstract][Full Text] [Related]
17. [Lysogenic conversion as a factor influencing tolerance to vancomycin in Staphylococcus aureus].
Młynarczyk G; Młynarczyk A; Zabicka D; Jeljaszewicz J
Med Dosw Mikrobiol; 1997; 49(1-2):13-7. PubMed ID: 9411067
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of cefoperazone against clinical isolates of Enterobacteriaceae, Pseudomonas and Staphylococcus.
Olarte J
Clin Ther; 1980; 3(Spec Issue):130-3. PubMed ID: 6446386
[No Abstract] [Full Text] [Related]
19. [Bacteriophage types of methicillin--resistant Staphylococcus aureus strains isolated in 2005-2006 in the Gdańsk area and their resistance to other antibiotics].
Wiśniewska K; Garbacz K; Piechowicz L
Med Dosw Mikrobiol; 2007; 59(4):279-85. PubMed ID: 18416119
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulating properties of newer cephalosporins: a preliminary classification.
Labro M; Bryskier A
Chemioterapia; 1987 Jun; 6(2 Suppl):219-21. PubMed ID: 3334561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
